OA08754A - Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. - Google Patents

Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Info

Publication number
OA08754A
OA08754A OA59416A OA59416A OA08754A OA 08754 A OA08754 A OA 08754A OA 59416 A OA59416 A OA 59416A OA 59416 A OA59416 A OA 59416A OA 08754 A OA08754 A OA 08754A
Authority
OA
OAPI
Prior art keywords
formula
derivative
see diagramm
iii
compound
Prior art date
Application number
OA59416A
Other languages
English (en)
French (fr)
Inventor
Vincent Michel
Remond Georges
Laubie Michel
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of OA08754A publication Critical patent/OA08754A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
OA59416A 1987-08-28 1988-08-26 Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. OA08754A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712013A FR2619813B1 (fr) 1987-08-28 1987-08-28 Nouveaux derives de l'acide aza - 2 bicyclooctane carboxylique - 3, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
OA08754A true OA08754A (fr) 1989-03-31

Family

ID=9354475

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59416A OA08754A (fr) 1987-08-28 1988-08-26 Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Country Status (16)

Country Link
US (1) US4959372A (pt)
EP (1) EP0305297B1 (pt)
JP (1) JPS6471875A (pt)
AT (1) ATE52789T1 (pt)
AU (1) AU612689B2 (pt)
CA (1) CA1327800C (pt)
DE (1) DE3860148D1 (pt)
DK (1) DK170978B1 (pt)
ES (1) ES2031616T3 (pt)
FR (1) FR2619813B1 (pt)
GR (1) GR3000677T3 (pt)
IE (1) IE60505B1 (pt)
NZ (1) NZ225943A (pt)
OA (1) OA08754A (pt)
PT (1) PT88357B (pt)
ZA (1) ZA886368B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655989B1 (fr) * 1989-12-20 1992-02-28 Adir Nouveaux derives d'amino-acides substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5458883A (en) * 1994-01-12 1995-10-17 Duke University Method of treating disorders of the eye
JP2004500906A (ja) * 1999-11-12 2004-01-15 ルーベン，　レオ 電気的調節および化学的調節のための心臓デバイス、ならびに心肺障害の処置のための血管作用性腸ペプチド
MXPA03008636A (es) 2001-03-26 2003-12-08 Kotobuki Pharmaceutical Co Ltd Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2492381A1 (fr) * 1980-10-21 1982-04-23 Science Union & Cie Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3227055A1 (de) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung

Also Published As

Publication number Publication date
JPS6471875A (en) 1989-03-16
GR3000677T3 (en) 1991-09-27
EP0305297B1 (fr) 1990-05-16
FR2619813B1 (fr) 1991-05-03
AU612689B2 (en) 1991-07-18
IE882599L (en) 1989-02-28
DK472788A (da) 1989-03-01
PT88357B (pt) 1995-03-31
PT88357A (pt) 1989-06-30
US4959372A (en) 1990-09-25
DE3860148D1 (de) 1990-06-21
AU2159488A (en) 1989-03-09
CA1327800C (fr) 1994-03-15
ATE52789T1 (de) 1990-06-15
DK170978B1 (da) 1996-04-09
EP0305297A1 (fr) 1989-03-01
IE60505B1 (en) 1994-07-27
ES2031616T3 (es) 1992-12-16
DK472788D0 (da) 1988-08-24
FR2619813A1 (fr) 1989-03-03
ZA886368B (en) 1989-05-30
NZ225943A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
US4035507A (en) Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
AU582600B2 (en) Dipeptide compounds having pharmaceutical activity and compositions containing them
KR960004858B1 (ko) 프롤리날 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
HU209413B (en) Method for producing 2-azabicyclo [3.1.0] hexane-3-carboxylic acid derivatives as well as their physiologically acceptable salts
US3998799A (en) Novel, transient pro-drug forms of l-dopa
RU96118225A (ru) Циклопептиды, способ их получения, содержащая их фармацевтическая композиция, способ ее получения, способ борьбы с заболеваниями, способ получения иммобилизированных лигандов, способ очистки интегринов
JPS6120544B2 (pt)
HU188439B (en) Process for producing amino acid derivatives substituted by hexahydro-indole and pharmaceutics containing them as active substance
PT91539B (pt) Processo para a preparacao de novos derivados peptidicos com accao antagonista do neuropeptido y
US4065566A (en) N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same
WO1988006448A1 (en) Prostaglandins useful for lowering intraocular pressure
OA08754A (fr) Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
CS200513B2 (en) Process for preparing omega-aminoacylamidic compounds
JPH08502495A (ja) 新規な７−（５−置換−シクロペンチル）及び（５−置換−シクロペンテニル）ヘプチルアルコール、ヘプチルアミン及びヘプタン酸アミド、及びこれらの新規化合物の投与による哺乳類の眼球内圧を低下させる方法
EP0046292A1 (en) Substituted caprylolactam derivatives as antihypertensives, process for preparing and pharmaceutical composition comprising them
FR2392023A1 (fr) Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant
EP0203450B1 (de) Neue Derivate bicyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
WO2018056530A1 (ko) 퇴행성 뇌질환 예방 또는 치료용 약학 조성물
DE3462261D1 (en) Derivatives of isoindoledicarboxylic acids, their preparation and pharmaceutical compositions thereof
Chen et al. Synthesis of 2 (S)‐benzyl‐3‐[hydroxy (1′(R)‐amino ethyl) phosphinyl] propanoyl‐L‐3‐[125I]‐iodotyrosine: a radiolabelled inhibitor of aminopeptidase N
US4372973A (en) 16-Amino-postaglandin derivatives, their acid addition salts, and a process for the preparation thereof
KR910002787A (ko) 아크릴산 아미드유도체, 이들의 제조방법, 이들을 함유하는 약리학적 조성물 및 이들을 사용하는 약품
JPH01168655A (ja) ベンズアミド誘導体
PT99964A (pt) Derivados de partricina processo para a sua preparacao e composicoes farmaceuticas que os contem